Patents/Assignees

CENTIVAX, Inc.

3 patents in portfolio

US12534513utility2026
Anti-sars-cov-2 Antibodies Derived from 2DD8
0 cites
US12043647utility2024
Epitope Focusing by Variable Effective Antigen Surface Concentration
0 cites
US11560409utility2023
Epitope Focusing by Variable Effective Antigen Surface Concentration
0 cites